Yeah....very exciting times for RAP, but don't buy the shares,...

Currently unlisted. Proposed listing date: 4 SEPTEMBER 2024 #

First 101 Last

Share
Profile

Follow
AlCp

27,899 Posts.

1797

30/09/19

20:43

Post #: 40648763
Share

Originally posted by Deadant ↑

The fool is now saying good things. oh how sweet it sounds.
===================

The good news for ResApp shareholders is that for all three AHI thresholds, the area under the receiver operating characteristic curve (AUC) was greater than 0.91. This demonstrates that ResApp’s algorithms, when used at-home, have an excellent ability to identify mild, moderate, or severe OSA.
Interestingly, in a recent ResMed Inc. (ASX: RMD)presentation, it revealed that research shows that less than 20% of those with OSA have been diagnosed or treated. So there certainly could be a large market opportunity for ResApp if it can successfully diagnose people through a smartphone app.
ResApp’s CEO, Tony Keating, was pleased with the results. He said: “We achieved excellent performance previously during our in-laboratory sleep studies and it is great to see the same high levels of performance replicated in our intended use setting, in peoples’ homes.”
Mr Keating also referenced the same data used by ResMed. Adding: “Nearly one billion people suffer from sleep apnoea and 80% of those with moderate or severe sleep apnoea remain undiagnosed. By delivering a highly scalable, low cost smartphone app for OSA screening we have a huge opportunity to reduce the health and economic impact of undiagnosed OSA. We will now move forward into the regulatory submission and commercialisation phases of this exciting project.”
Whilst I think ResApp could be one to watch after this update, I would still buy these exciting growth shares ahead of it at this point.

Expand

Yeah....very exciting times for RAP, but don't buy the shares, there are others (nice "logic")

RAP Price at posting: 24.5¢ Sentiment: Buy Disclosure: Held
2 Upvote

0 Great analysis

Reply

Top Stories

Week 46 Wrap: Copper hits 2mth low as Trump threatens net zero pace; US rally fades; HotCopper’s picks

IRX

InhaleRX gains approval for clinical trial to test non-opioid therapy for cancer pain

CLE

Cyclone signs MOU with Vale for development of Iron Bear play

3DA

To make modern missiles, you need 3D Printing. And in that gold rush, Amaero is selling shovels

BTH

Bigtincan's Board backs Investcorp offer: Why a NASDAQ listing could be game-changing

CUF

CuFe sells its Crossroads gold royalty to Northern Star for $4M cash; says better than waiting for mine launch

HotCopper Highlights: Your most watched stocks for Week 46, 2024

GDM

Banshee's historic trenches prove rich in antimony and gold for GDM

BNL

Blue Star Helium sees approval for five more wells at 'Galactica/Pegasus' project in Colorado

EEG

NT Gov't delivers environmental approval for Empire Energy's Beetaloo Carpentaria pilot gas play

First 101 Last

Add RAP (ASX) to my watchlist

Yeah....very exciting times for RAP, but don't buy the shares,...

Top Stories

Week 46 Wrap: Copper hits 2mth low as Trump threatens net zero pace; US rally fades; HotCopper’s picks

InhaleRX gains approval for clinical trial to test non-opioid therapy for cancer pain

Cyclone signs MOU with Vale for development of Iron Bear play

To make modern missiles, you need 3D Printing. And in that gold rush, Amaero is selling shovels

Bigtincan's Board backs Investcorp offer: Why a NASDAQ listing could be game-changing

CuFe sells its Crossroads gold royalty to Northern Star for $4M cash; says better than waiting for mine launch

HotCopper Highlights: Your most watched stocks for Week 46, 2024

Banshee's historic trenches prove rich in antimony and gold for GDM

Blue Star Helium sees approval for five more wells at 'Galactica/Pegasus' project in Colorado

NT Gov't delivers environmental approval for Empire Energy's Beetaloo Carpentaria pilot gas play

Featured News